Buy & Sell McDonald's Corp (MCD) – McDonald's Corp Price Today
Aura AI Summary
Key Stats
- $200.70BMarket Cap
- Consumer CyclicalSector
- -19.49%3M Drawdown
- $254.41BEnterprise Value
- 2.63%Dividend Yield
- 24% Buy | 76% SellTrading Activity
- 158 daysTypical Hold Time
McDonald's Corp (MCD) is currently valued at a market capitalization of $200.70B, with an enterprise value of $254.41B. Over the past 52 weeks, McDonald's Corp has traded between a low of $274.6 and a high of $341.06, highlighting its annual price range. Over the past three months, McDonald's Corp has recorded a drawdown of -19.49%, reflecting recent price volatility. McDonald's Corp offers a dividend yield of 2.63%, with the most recent dividend of $1.86 paid on 03 Mar 26. On average, investors hold McDonald's Corp for approximately 158 days, indicating typical investor behavior on the platform.
About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Most Recent News
Li Auto adopts Arteris tech for AI-powered SoCs in new L9 Livis SUV, boosting autonomous driving capabilities.
Li Auto has integrated Arteris' FlexNoC 5 network-on-chip IP and Magillem software into its proprietary autonomous driving SoCs for the new L9 Livis SUV. This technology supports AI data movement and integration, enabling the vehicle to perform 2,560...

Arteris tech powers Li Auto's new L9 Livis SUV with advanced AI and SoC integration.
Arteris, Inc. announced its system IP technology is adopted by Li Auto for its new L9 Livis flagship SUV, integrating the Mach M100 autonomous driving SoC. This collaboration enhances AI data movement and system efficiency, meeting high performance, ...

Disc Medicine faces class action after FDA rejects drug application, stock drops 22%.
Disc Medicine, Inc. is facing a class action lawsuit after the FDA issued a Complete Response Letter rejecting its new drug application for bitopertin due to uncertainties requiring more evidence. This announcement caused the company's stock to fall ...
